全文获取类型
收费全文 | 929篇 |
免费 | 355篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 27篇 |
妇产科学 | 14篇 |
基础医学 | 3篇 |
口腔科学 | 14篇 |
临床医学 | 198篇 |
内科学 | 535篇 |
皮肤病学 | 13篇 |
神经病学 | 49篇 |
特种医学 | 13篇 |
外科学 | 111篇 |
综合类 | 3篇 |
预防医学 | 89篇 |
眼科学 | 6篇 |
药学 | 6篇 |
肿瘤学 | 179篇 |
出版年
2024年 | 9篇 |
2023年 | 104篇 |
2022年 | 32篇 |
2021年 | 69篇 |
2020年 | 75篇 |
2019年 | 31篇 |
2018年 | 75篇 |
2017年 | 103篇 |
2016年 | 83篇 |
2015年 | 75篇 |
2014年 | 114篇 |
2013年 | 114篇 |
2012年 | 48篇 |
2011年 | 28篇 |
2010年 | 64篇 |
2009年 | 75篇 |
2008年 | 23篇 |
2007年 | 16篇 |
2006年 | 30篇 |
2005年 | 19篇 |
2004年 | 11篇 |
2003年 | 11篇 |
2002年 | 6篇 |
2001年 | 13篇 |
2000年 | 5篇 |
1999年 | 13篇 |
1998年 | 5篇 |
1997年 | 9篇 |
1996年 | 7篇 |
1995年 | 2篇 |
1994年 | 4篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1984年 | 2篇 |
1983年 | 1篇 |
排序方式: 共有1286条查询结果,搜索用时 31 毫秒
61.
62.
Eric Black-Maier MD Michael Rehorn MD Rahul Loungani MD Daniel J. Friedman MD Fawaz Alenezi MD Kyle Geurink MD Sean D. Pokorney MD James P. Daubert MD Albert Y. Sun MD Brett D. Atwater MD Kevin P. Jackson MD Donald D. Hegland MD Kevin L. Thomas MD Tristram D. Bahnson MD Michel G. Khouri MD Jonathan P. Piccini MD MHS 《Pacing and clinical electrophysiology : PACE》2020,43(9):913-921
63.
Thomas W. Lycan DO MHS Fang-Chi Hsu PhD Christine S. Ahn MD Alexandra Thomas MD Francis O. Walker MD Omar P. Sangueza MD Yusuke Shiozawa MD PhD Sun Hee Park PhD Christopher M. Peters PhD Edgar Alfonso Romero-Sandoval MD Susan A. Melin MD Steven Sorscher MD Katherine Ansley MD Glenn J. Lesser MD Michael S. Cartwright MD Roy E. Strowd MD 《Muscle & nerve》2020,61(5):587-594
64.
65.
66.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
67.
68.
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
下载免费PDF全文
![点击此处可从《Catheterization and cardiovascular interventions》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jean‐Pierre Déry MD MHS Kenneth W. Mahaffey MD Pierluigi Tricoci MD PhD Harvey D. White DSC Mohua Podder PhD Cynthia M. Westerhout PhD David J. Moliterno MD Robert A. Harrington MD Edmond Chen MD John Strony MD Frans Van de Werf MD Khaled M. Ziada MD Claes Held MD PhD Philip E. Aylward MD Paul W. Armstrong MD Sunil V. Rao MD 《Catheterization and cardiovascular interventions》2016,88(2):163-173
69.
Review of high‐risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology
下载免费PDF全文
![点击此处可从《Head & neck》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Samuel Lamarre Skulsky BSc Barry O'Sullivan FRCSI MCh Orla McArdle MB BCh Peter J. Conlon MB MHS FRCPI FRCP FACP James Paul O'Neill FRCSI MMSc MBA MD ORL‐HNS 《Head & neck》2017,39(3):578-594
Cutaneous squamous cell carcinoma (SCC) is a malignancy that arises from epidermal keratinocytes. Although the majority of cutaneous SCC cases are easily treated without further complication, some behave more aggressively and carry a poor prognosis. These “high‐risk” cutaneous SCCs commonly originate in the head and neck and have an increased tendency toward recurrence, local invasion, and distant metastasis. Factors for high‐risk cutaneous SCC include large size (>2 cm), a deeply invasive lesion (>2 mm), incomplete excision, high‐grade/desmoplastic lesions, perineural invasion (PNI), lymphovascular invasion, immunosuppression, and high‐risk anatomic locations. Both the National Comprehensive Cancer Network® (NCCN®) and the American Joint Committee on Cancer (AJCC) identify several of these high‐risk features of cutaneous SCC. The purpose of this article was to review the high‐risk features included in these guidelines, as well as their notable discrepancies and omissions. We also provide a brief overview of current prophylactic measures, surgical options, and adjuvant therapies for high‐risk cutaneous SCC. © 2016 Wiley Periodicals, Inc. Head Neck 39: 578–594, 2017 相似文献
70.
Birju Patel BS Sharon Turban MD MHS Cheryl Anderson PhD MPH Jeanne Charleston RN Edgar R. Miller MD PhD Lawrence J. Appel MD MPH 《Journal of clinical hypertension (Greenwich, Conn.)》2010,12(6):389-395
J Clin Hypertens (Greenwich). 2010;12:389–395. ©2010 Wiley Periodicals, Inc. Home blood pressure (HBP) monitoring is now recommended as a routine component of blood pressure management in patients with known or suspected hypertension. Over the last few years, a large number of Web sites, commonly termed Personal Health Records, have been developed so that patients can manage and present HBP readings. The objective of this report is to describe and compare these Web sites. A list of 33 desirable Web site features, organized into 4 categories, was developed. Between June and August of 2009, a total of 60 Web sites was identified, of which 20 were free or free to try. Each of the 20 Web sites displayed HBP readings in tabular and graphical formats, most offered an option to print results in tabular (70%) and graphical (70%) form, and many (47%) could download HBP data from Microsoft HealthVault. In contrast, none of the Web sites directly linked with common electronic medical records. Overall, Web sites offered between 41% and 77% of the 33 features considered desirable. In conclusion, there is considerable variation in available features on Web sites used to manage HBP data. Information presented in this report should be useful to physicians and patients in selecting a Web site for managing and presenting HBP readings and ultimately improving blood pressure control. 相似文献